Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Myths, Evidence, and the Future of Tobacco Treatment, 9/25/2020 8:00:00 AM - 9/25/2023 9:00:00 AM, Despite a successful public health campaign, there are still millions of smokers in the United States and only 5% receive effective treatment to support smoking cessation. There are regional hot spots as well as identifiable groups in which smoking rates remain high. Using effective assessment methods, perseverance, and combinations of personalized medication and counseling treatments, quit rates can improve dramatically. Smoking cessation dramatically improves overall health, though risk for some smoking related diseases can persist long after a successful quit date.
Presenter
Hilary A. Tindle, MD, MPH
Associate Professor of Medicine
Vanderbilt University Medical Center
About our presenter:
Dr. Hilary Tindle is a physician scientist, Associate Professor of Medicine, and the William Anderson Spickard, Jr., MD Chair in Medicine at Vanderbilt University Medical Center, and is board-certified in Internal Medicine and Addiction Medicine. Clinically, Dr. Tindle directs tobacco treatment services which leverage the electronic health record to deliver evidence-based treatment, including direct electronic referral to community-based services such as state quit lines.
Learning Outcome(s)
Participants will be able to dispel common myths held by providers and patients about tobacco treatment, discuss core evidence for treatment of tobacco use as a chronic condition and introduce future directions in tobacco treatment, including opportunities to leverage pharmacogenomics and other approaches to precision care.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic References
See presentation for bibliographic sources to allow for further study.
Presenter
Hilary A. Tindle, MD, MPH
Associate Professor of Medicine
Vanderbilt University Medical Center
About our presenter:
Dr. Hilary Tindle is a physician scientist, Associate Professor of Medicine, and the William Anderson Spickard, Jr., MD Chair in Medicine at Vanderbilt University Medical Center, and is board-certified in Internal Medicine and Addiction Medicine. Clinically, Dr. Tindle directs tobacco treatment services which leverage the electronic health record to deliver evidence-based treatment, including direct electronic referral to community-based services such as state quit lines.
Learning Outcome(s)
Participants will be able to dispel common myths held by providers and patients about tobacco treatment, discuss core evidence for treatment of tobacco use as a chronic condition and introduce future directions in tobacco treatment, including opportunities to leverage pharmacogenomics and other approaches to precision care.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic References
See presentation for bibliographic sources to allow for further study.
